Insurers, including Aetna, Wellpoint, and others, are moving forward with plans to stop paying for care and to prevent patients from being charged for care associated with serious errors-especially preventable ones.
Insurers, including Aetna, Wellpoint, and others, are moving forward with plans to stop paying for care and to prevent patients from being charged for care associated with serious errors-especially preventable ones. These mistakes could include the death or serious disability of a mother in a low-risk pregnancy, nosocomial bedsores, discharging an infant to the wrong person, or performing the wrong procedure, among others.
Some in the industry worry that the strategy could cause medical costs to rise as hospitals pass along or absorb expenses for putting in place safety and screening procedures to prevent errors. There is also concern that providers "may find ways to turn away or divert patients at greatest risk of developing infections or bedsores," reported The New York Times (1/15/2008).
Insurers say triggering safety improvements within hospitals and reducing medical costs are the goals of their plans. The strategy also puts them in line with the Medicare program: In October, Medicare will stop paying for the extra costs associated with preventable injuries or infections that occur when a patient is in the hospital.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More